Environmental reservoirs of high-risk ESBL- and carbapenemase-producing E. coli and Klebsiella in maternity wards in Yaounde (Cameroon): Whole-genome sequencing and antimicrobial susceptibility studies

This study reveals that maternity ward surfaces in Yaounde, Cameroon, serve as critical reservoirs for multidrug-resistant, high-risk ESBL- and carbapenemase-producing *E. coli* and *Klebsiella* clones, underscoring the urgent need for enhanced infection control and genomic surveillance to protect vulnerable maternal and neonatal populations.

The Gist

Imagine a maternity ward as a busy, high-stakes airport terminal. The passengers are mothers and newborns, who are like fragile, unseasoned travelers just starting their journey. The "security checkpoints" are the doctors and nurses, and the "runways" are the beds, tables, and door handles.

This paper is a report from a team of detectives (scientists) who went to four of these "airports" in Yaoundé, Cameroon, to see if the terminal itself was contaminated with invisible, dangerous "stowaways."

Here is the story of what they found, broken down into simple concepts:

1. The Invisible Invaders

The detectives were looking for a specific type of "super-bug": bacteria called E. coli and Klebsiella that have learned to wear bulletproof vests against antibiotics. These are called ESBL and Carbapenemase producers.

• The Analogy: Think of normal bacteria as regular thieves. Antibiotics are the police. These "super-bugs" are like thieves who have stolen the police uniforms and are wearing Kevlar vests. When the police (antibiotics) try to stop them, the bullets just bounce off.

2. The Crime Scene: The Hospital Surfaces

The team didn't just look at sick patients; they swabbed the environment. They wiped down bed rails, delivery tables, door handles, sinks, and even checked the air.

• The Finding: They found these super-bugs hiding on the surfaces, like dust bunnies in a corner, but much more dangerous.
• The Air vs. The Floor: Interestingly, the air was clean, but the surfaces were dirty. It's like the wind is safe, but the floor is covered in sticky, invisible glue that traps these bad bugs. The biggest "hotspots" were the busiest areas: delivery rooms and neonatal units.

3. The "Bulletproof Vests" (Resistance)

The scientists tested these bugs against 13 different types of antibiotics (the police force).

• The Result: The bugs were incredibly tough. They were resistant to almost everything, including the "heavy artillery" (third-generation cephalosporins).
• The Shock: They were even resistant to Meropenem, which is often considered the "nuclear option" or the last line of defense in hospitals.
• The Good News: They were still vulnerable to two specific drugs (Colistin and Imipenem), but relying on Colistin is risky because it can be toxic to the kidneys, like using a sledgehammer to crack a nut.

4. The "Passports" and "Family Trees" (Genomics)

The researchers didn't just look at the bugs; they took their DNA "fingerprints" (Whole Genome Sequencing). This is like checking the passport and family tree of every thief to see where they came from.

• Global Travelers: They found that these weren't just local bugs. They were globally famous criminal gangs (specific lineages like ST131 and ST1193) that are causing trouble all over the world.
• The Plasmid "Backpacks": The most dangerous part is how these bugs share their bulletproof vests. They carry tiny, circular pieces of DNA called plasmids.
  • The Metaphor: Imagine the bacteria are backpackers. These plasmids are backpacks that they can swap with each other. One bug can pick up a backpack full of resistance genes from another bug and instantly become immune to a new drug. The study found that these "backpacks" (plasmids) are very good at carrying multiple types of resistance at once.

5. The "Weapons" (Virulence)

These bugs aren't just resistant; they are also aggressive. The study found they carry virulence factors, which are like special weapons.

• The Weapons: They have tools to stick to surfaces (adhesins), steal iron from the body (iron acquisition), and even produce toxins.
• The Risk: This means if a mother or baby gets infected, the bacteria won't just sit there; they will actively attack, stick to organs, and cause severe illness.

6. The Big Picture: Why This Matters

The main takeaway is that the hospital environment itself has become a reservoir (a storage tank) for these super-bugs.

• The Cycle: A mother comes in, touches a contaminated bed rail, gets colonized, gets sick, and then the bacteria stay on the rail for the next patient. It's a cycle of infection that happens even if the doctors wash their hands perfectly, because the room is dirty.
• The Vulnerability: Mothers and newborns are the most vulnerable people in the world. Their immune systems are weak. Finding these "super-bugs" in their environment is like finding a landmine in a playground.

The Conclusion & Call to Action

The authors are sounding the alarm. They say:

1. Clean the Room, Not Just the Hands: We need to focus heavily on disinfecting surfaces, not just hand hygiene.
2. Watch the Bugs: We need to use advanced DNA testing (genomics) to track these bugs before they cause outbreaks.
3. Stop the Overuse: We need to be smarter about which antibiotics we use so we don't accidentally train the bugs to become even stronger.

In short: The maternity wards in Yaoundé are currently hiding a dangerous, invisible army of super-bugs on their surfaces. These bugs are tough, travel globally, share their defenses, and are ready to attack the most vulnerable people in the hospital. The solution requires better cleaning, smarter drug use, and high-tech tracking to keep mothers and babies safe.

Technical Summary

Title

Environmental reservoirs of high-risk ESBL- and carbapenemase-producing E. coli and Klebsiella in maternity wards in Yaounde (Cameroon): Whole-genome sequencing and antimicrobial susceptibility studies.

1. Problem Statement

• Context: Maternity wards in low- and middle-income countries (LMICs), particularly in sub-Saharan Africa, are high-risk environments for Healthcare-Associated Infections (HAIs) due to high patient turnover, invasive procedures, and vulnerable populations (neonates and mothers).
• Gap: While antimicrobial resistance (AMR) in clinical isolates is documented, there is a significant lack of data integrating environmental sampling with phenotypic resistance profiling and Whole-Genome Sequencing (WGS) in these settings.
• Specific Issue: The hospital environment acts as a reservoir for multidrug-resistant (MDR) pathogens like Extended-Spectrum Beta-Lactamase (ESBL)-producing Escherichia coli and Klebsiella spp., yet the extent of environmental contamination and the genomic mechanisms driving resistance in Cameroonian maternity wards remain underexplored.

2. Methodology

• Study Design & Setting: A cross-sectional environmental study conducted from January to November 2024 across four maternity wards in Yaounde, Cameroon (one tertiary hospital and three district hospitals).
• Sampling Strategy:
  • 1,519 samples collected monthly, including surface swabs (high-touch areas: bed rails, delivery tables, sinks, etc.) and passive air sampling (settling plates).
  • Selection Criteria: Surfaces were swabbed using sterile swabs in buffered peptone water; air samples used MacConkey agar supplemented with cefotaxime (2 mg/L).
• Isolation & Identification:
  • Selective isolation on MacConkey agar with cefotaxime.
  • Confirmation of ESBL production via CHROMagar™ ESBL and biochemical identification (API 20E).
• Antimicrobial Susceptibility Testing (AST):
  • Performed via Kirby–Bauer disk diffusion on Mueller–Hinton agar.
  • Tested against 13 antibiotics (including carbapenems, cephalosporins, fluoroquinolones, and aminoglycosides) following EUCAST 2024 guidelines.
• Genomic Analysis (WGS):
  • Sequencing: Illumina HiSeq 2500 (250 bp paired-end reads, min. 30x coverage).
  • Bioinformatics: De novo assembly (SPAdes), MLST (PubMLST), plasmid detection (PlasmidFinder), and resistance/virulence gene identification (ABRicate against ResFinder, CARD, ARG-ANNOT, VFDB).
  • Phylogenetics: Core-genome alignment (Roary) and Maximum Likelihood tree construction (IQ-TREE).
  • Network Analysis: Construction of plasmid-antibiotic resistance gene (ARG) association networks.

3. Key Results

• Isolation Rates:
  • 19 ESBL-producing isolates were recovered exclusively from surface samples; no ESBL producers were found in air samples.
  • Species Distribution: 15 E. coli and 4 Klebsiella (2 K. pneumoniae, 2 K. quasipneumoniae).
  • Spatial Distribution: Highest contamination at the tertiary hospital (Yaounde Central Hospital), followed by district hospitals. Isolates were concentrated in high-contact areas (delivery rooms, neonatal units, operating theaters).
• Antimicrobial Resistance (Phenotype):
  • Multidrug Resistance (MDR): All 19 isolates were MDR (resistant to ≥8 antibiotics).
  • High Resistance: Universal resistance to amoxicillin, amoxicillin-clavulanate, ciprofloxacin, and third-generation cephalosporins (ceftriaxone, ceftazidime, cefotaxime).
  • Carbapenems: All isolates were resistant to meropenem, but susceptible to imipenem (except one isolate).
  • Last-Resort Drugs: 18/19 isolates were susceptible to colistin; 1 was resistant.
• Genomic Characterization:
  • Sequence Types (STs): Identified globally disseminated high-risk lineages:
    • E. coli: ST131, ST1193, ST410, ST617, ST73, ST448, and others.
    • Klebsiella: ST1324 (K. pneumoniae) and ST489 (K. quasipneumoniae).
  • Resistance Genes (ARGs):
    • ESBLs: Predominantly bla_CTX-M-15, along with bla_{CTX-M-27/55/98}, bla_SHV, and bla_OKP-B-6.
    • Carbapenemases: bla_NDM-1 (New Delhi Metallo-beta-lactamase) and bla_OXA-48-like.
    • AmpC: bla_CMY-2/6 (associated with cefoxitin resistance).
  • Plasmid Dynamics:
    • Epidemic plasmids identified: IncF (IncFIA, IncFIB, IncFII), IncA/C2, IncL/M, and IncHI1B.
    • Strong associations found between IncF/IncL/M plasmids and carbapenemase genes (bla_NDM, bla_OXA-48).
  • Virulence Factors:
    • Isolates harbored ExPEC (Extraintestinal Pathogenic E. coli) virulence profiles, including adhesins (fim, pap), iron acquisition systems (ent, fep, iuc), and invasion genes (ibeB/C).
    • Notably, an ST73 isolate carried the colibactin gene cluster, associated with DNA damage and increased virulence.

4. Key Contributions

• First Integrated Study: This is one of the first studies in Cameroon to combine environmental sampling, phenotypic AST, and high-resolution WGS specifically within maternity wards.
• Environmental Reservoir Confirmation: Demonstrates that maternity ward surfaces are active reservoirs for high-risk, globally disseminated clones (ST131, ST1193, ST1324), not just transient clinical isolates.
• Mechanistic Insight: Reveals that resistance is driven by epidemic plasmids (IncF, IncL/M, IncA/C2) that co-harbor ESBLs, carbapenemases, and virulence factors, facilitating the spread of "superbugs."
• Phenotype-Genotype Correlation: Validated that while phenotypic resistance generally matches genotypic data, discrepancies in carbapenem susceptibility (meropenem vs. imipenem) highlight the complexity of enzyme expression and permeability factors, emphasizing the need for genomic surveillance.

5. Significance and Implications

• Public Health Threat: The presence of carbapenem-resistant (meropenem-resistant) and ESBL-producing clones in maternity wards poses a direct, life-threatening risk to neonates and postpartum mothers, who are highly susceptible to sepsis.
• Infection Prevention & Control (IPC): Findings underscore the failure of current cleaning protocols to eliminate MDR pathogens from high-touch surfaces. The study calls for reinforced environmental disinfection and strict hand hygiene.
• Surveillance Strategy: Highlights the necessity of integrating genomic surveillance into routine AMR monitoring in LMICs to detect high-risk clones early, rather than relying solely on phenotypic testing.
• Antimicrobial Stewardship (AMS): The detection of carbapenemase producers suggests a need to review empirical antibiotic prescribing practices in maternity units to reduce selective pressure.
• Policy Recommendation: Urgent implementation of targeted environmental decontamination and genomic monitoring is required to safeguard maternal and neonatal health in resource-limited settings.

Limitations

• Sample Size: The number of Klebsiella isolates was small (n=4), limiting statistical power for species-specific comparisons.
• Study Design: Cross-sectional nature prevents establishing direct transmission links between environmental isolates and patient infections.
• Sequencing: Short-read sequencing was used, which limits the ability to fully resolve complex plasmid structures compared to long-read sequencing.
• Contextual Data: Lack of data on specific cleaning schedules, patient flow, and antimicrobial usage rates in the wards.